The Malaria Synergy Program (MSP) brings together experts with complementary expertise into a multidisciplinary program to address major roadblocks to achieving the goals of malaria elimination in the Asia-Pacific region and globally.
Malaria is a major global health problem. Progress in reducing the global burden stalled in 2015 and the burden increased in 2020. The Malaria Synergy Program aims to generate new knowledge, tools, and strategies to overcome major roadblocks in malaria detection, treatment, and prevention to accelerate progress towards elimination of malaria caused by P. Falciparum and P. vivax.
2023–2028.
The Malaria Synergy Program investigators and their teams will focus on developing novel approaches to optimise drug treatment, achieving highly efficacious and long-lasting vaccines, and developing novel tools to map and discover drivers of malaria transmission.
Our three core themes are:
National Health and Medical Research Council (NHMRC)